David Weill, Director at TransMedics Group, Inc. (TMDX), sold 11,868 shares at $76.51 ($910K) on 2023-02-27, disclosed to the SEC on 2023-02-28.
Open-market sale of $910k TMDX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $76.51 | 4,970 | $380K | 41.8% |
| 2 | $76.51 | 4,970 | $380K | 41.8% |
| 3 | $77.64 | 964 | $75K | 8.2% |
| 4 | $77.64 | 964 | $75K | 8.2% |
| Total | $76.69 avg | 11,868 | $910K | 100% |
| Filing → |
| TMDX | SELL | 2025-12-05 | $1.4M | — | Filing → |
| TMDX | SELL | 2025-05-23 | $181K | — | Filing → |
| TMDX | SELL | 2024-05-31 | $338K | — | Filing → |